Omnicare, Inc. OCR today confirmed
that it has entered into a confidentiality and joint defense agreement with
PharMerica Corporation PMC. Under the agreement, the companies will
exchange certain information in furtherance of the analysis of the regulatory
approval process relating to Omnicare's previously announced offer to purchase
all outstanding shares of PharMerica common stock for $15.00 per share.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in